Healthcare
Cinven acquires BC Partners' Synlab to merge it with Labco
Deal values Synlab at €1.8bn
Apax’s Amplitude in €239m listing
Shareholders to reap €50m in proceeds from sale of existing shares
ViraTherapeutics scores €3.6m series-A
Investors include Boehringer Ingelheim Venture Fund and EMBL Ventures
Duke Street to fully exit Biomnis in trade sale
GP relinquished majority stake as part of 2013 restructuring
Zeus Capital appoints Walker as head of healthcare corporate finance
New recruit has experience of IPOs, secondary fundraising and M&A
Principia leads €3m series-A for WISE
Deal marks GP's first investment from third vehicle
Equistone exits Sunrise Medical to Nordic Capital
Deal value for mobility products company reported to be around €450m
Apax and Nordic Capital to list Capio
IPO values company equity at SEK 6.84bn
Healthtech presents opportunity regardless of sector specialism
Healthtech offers world of opportunity for private equity
Idinvest and Kurma in €3m seed round for BioSerenity
Maiden deal for Kurma Diagnostics after €33m first close
BC Partners acquires Pharmathen
Deal reportedly values Greek pharmaceutical company at more than €400m
Mid Europa’s Walmark acquires Pneumolan
Deal marks Walmark's second purchase from Novascon
Bridges Ventures creates pharmacy platform
New company will focus on easing NHS burden
3i exits Labco to Cinven in €1.2bn SBO
Company scrapped IPO plans prior to sale
Kurma Diagnostics holds €33m first close
Fund aims at 15 investments around €500,000 mark
Industrifonden leads $5m series-A in Trialbee
Round sees VC return for second investment in Trialbee
Gimv exits Prosonix in £100m trade sale
Trade sale comes three years after Gimv's £5.7m investment
Parquest buys 5 Santé from Fontalvie
Deal builds platform of clinics across France
Care providers attract increasing share of PE healthcare deals
Overall healthcare deals are falling, but healthcare provider sub-segment is thriving
SHS closes fourth fund on €125m
Biotech vehicle raises more than double its predecessor
PE-backed STS Medical Group picks up Luigi Salvadori
Acquisition is carried out alongside existing shareholders
Seed Capital sells EpiTherapeutics to Gilead for $65m
Sale brings Seed Capital's total exit value to DKK 3bn for past year
Cathay leads €30m funding round for Echosens
First investment for firm's latest midcap vehicle
VC-backed Biocartis lists with €450m market cap
Biocartis raises €100m in offering